Benson; Jonathan D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Benson; Jonathan D..The latest application filed is for "targeting ligands for therapeutic compounds".

Company Profile

3.15.14

Benson; Jonathan D. - Madison WI
Benson; Jonathan D. - Stoughton WI
Benson; Jonathan D - Stoughton WI US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Targeting Ligands For Therapeutic Compounds App 20210189394 - Rozema; David B ; et al.	2021-06-24
Compositions and Methods for Inhibiting Gene Expression of Hif2alpha App 20210180066 - Wong; So ; et al.	2021-06-17
Compositions and methods for inhibiting gene expression of Hif2alpha Grant 10,927,373 - Wong , et al. February 23, 2	2021-02-23
Targeting Ligands For Therapeutic Compounds App 20190211333 - Rozema; David B. ; et al.	2019-07-11
Targeting ligands for therapeutic compounds Grant 10,246,709 - Rozema , et al.	2019-04-02
Disubstituted maleic anhydrides with altered kinetics of ring closure Grant 10,059,681 - Blokhin , et al. August 28, 2	2018-08-28
Compositions and Methods for Inhibiting Gene Expression of Hif2alpha App 20180230470 - Wong; So ; et al.	2018-08-16
Disulfide-containing alkyne linking agents Grant 10,047,361 - Almeida , et al. August 14, 2	2018-08-14
Compositions and methods for inhibiting gene expression of Hif2alpha Grant 9,976,141 - Wong , et al. May 22, 2	2018-05-22
Disulfide-Containing Alkyne Linking Agents App 20180023084 - Almeida; Aaron ; et al.	2018-01-25
Disulfide-containing alkyne linking agents Grant 9,803,201 - Almeida , et al. October 31, 2	2017-10-31
Targeting Ligands For Therapeutic Compounds App 20170253875 - Rozema; David B. ; et al.	2017-09-07
Compositions and Methods for Inhibiting Gene Expression of Hif2alpha App 20160348107 - Wong; So ; et al.	2016-12-01
Disubstituted maleic anhydrides with altered kinetics of ring closure Grant 9,481,661 - Blokhin , et al. November 1, 2	2016-11-01
Disubstituted Maleic Anhydrides with Altered Kinetics of Ring Closure App 20160272605 - Blokhin; Andrei V. ; et al.	2016-09-22
Disulfide-Containing Alkyne Linking Agents App 20160272971 - Almeida; Aaron ; et al.	2016-09-22
Peptide-based in vivo siRNA delivery system Grant 9,107,957 - Rozema , et al. August 18, 2	2015-08-18
In vivo polynucleotide delivery conjugates having enzyme sensitive linkages Grant 8,802,773 - Rozema , et al. August 12, 2	2014-08-12
Disubstituted Maleic Anhydrides with Altered Kinetics of Ring Closure App 20140128584 - Blokhin; Andrei V. ; et al.	2014-05-08
Peptide-Based In Vivo siRNA Delivery System App 20130281658 - Rozema; David B ; et al.	2013-10-24
Peptide-based in vivo siRNA delivery system Grant 8,501,930 - Rozema , et al. August 6, 2	2013-08-06
In vivo polynucleotide delivery conjugates having enzyme sensitive linkages Grant 8,426,554 - Rozema , et al. April 23, 2	2013-04-23
In Vivo Polynucleotide Delivery Conjugates Having Enzyme Sensitive Linkages App 20120172412 - Rozema; David B. ; et al.	2012-07-05
Peptide-Based In Vivo siRNA Delivery System App 20120165393 - Rozema; David B. ; et al.	2012-06-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.